BRCA1 and breast carcinoma: To test whether BRCA1-mutated ZNF251KD breast cancer cells are sensitive to DNA Polθ inhibitors, we treated MDA-MB-436 WT and ZNF251KD3 cells with Polθ polymerase inhibitors ART-558 and ART-81223 followed by the clonogenic assay.